U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 29 - September 4, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 29 - September 4, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 09/01/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/31/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; CAITLIN BOON;
Non FDA Participant/Group: Brendan Ring, Cronan McNamara (Creme Global);

Event Date: 09/02/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: RAM IYER;
Non FDA Participant/Group: Joe Reardon (National Association of State Departments of Agriculture);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/02/2021
Location: Virtual
Subject: Making It Plain: A Town Hall with the NFL Alumni Association and All Their Fans
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the NFL Alumni Town Hall

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 08/31/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: ANNE NORRIS; TRACEY FORFA; SIOBHAN DELANCEY; CHARLOTTE CONWAY; DAVID EDWARDS; JENNIFER ERICKSON; ASHLEY STEEL; ANTONIA MONIQUE SENNETT; WILLIAM FLYNN; JEANETTE MURPHY;
Non FDA Participant/Group: Representatives of the American Feed Industry Association (AFIA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

Event Date: 09/01/2021
Location: Virtual
Subject: Follow-up to Federal Register Notice of 08/09/2021 Concerning Implementation of Genus Decision
FDA Participant/Group: AMANDA EDMONDS; ELEANOR MAYER; ELIZABETH DICKINSON; JAMES ALLRED; VINCENT AMATRUDO; ELLEN FLANNERY; ELIZABETH JUNGMAN; DAVID MEDNICK; THINH NGUYEN;
Non FDA Participant/Group: Alberto Spinazzi, Andrew Betournay, Patrice Marchildon, Patti Smith, Vito DeBari (Bracco); Michael M. Gaba (Polsinelli);

 

Back to Top